Reversal of P-glycoprotein-mediated MDR by 5,7,3',4',5'-pentamethoxyflavone and SAR

Biochemical and Biophysical Research Communications
Cheol-Hee ChoiSang-Hyun Kim

Abstract

During screening for the flavonoid chemosensitizers, it was found that 5,7,3',4',5'-pentamethoxyflavone (PMF) was equipotent to verapamil in vitro with respect to the chemosensitizing effect. PMF appears to have a chemosensitizing effect not only by increasing the intracellular accumulation of the drugs without competition in a binding site of azidopine but also by interfering with the substrate-stimulated ATPase activity. Structure-activity relationship suggests that methoxylated substitution and its numbers or sites of the rings are more important than its hydroxylated counterparts in chemosensitization. Overall, PMF is anticipated to be a novel and highly potent second-generation flavonoid chemosensitizer because PMF has significant advantages of having a high therapeutic index, of being a non-transportable inhibitor, and of having a low possibility of drug interactions at the azidopine-binding site of Pgp.

References

Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S V AmbudkarI Pastan
Aug 15, 1989·Biochemical and Biophysical Research Communications·A R SafaM Agresti
Jan 1, 1989·Annual Review of Biochemistry·J A Endicott, V Ling
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·W F De AzevedoS H Kim
Jun 1, 1997·Molecular Pharmacology·S ScalaS E Bates
Oct 6, 1997·British Journal of Pharmacology·T WatanabeD Cohen
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·G ConseilA Di Pietro
Jul 5, 2001·Biochemical and Biophysical Research Communications·C OzvegyB Sarkadi
Apr 19, 2002·Journal of Medicinal Chemistry·Julie E PenzottiPeter D J Grootenhuis

❮ Previous
Next ❯

Citations

Feb 24, 2011·Journal of Medicinal Chemistry·Fabio BroccatelliGabriele Cruciani
Oct 7, 2005·Journal of Toxicology and Environmental Health. Part a·Eun Jeong Yoo, Byung Mu Lee
Nov 1, 2005·Drug Metabolism Reviews·Takaharu Mizutani, Asuka Hattori
Oct 13, 2006·Journal of Pharmaceutical Sciences·Denpong PatanasethanontMikihisa Takano
Nov 3, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Chadarat AmpasavateNusara Piyapolrungroj
Jan 13, 2009·Advanced Drug Delivery Reviews·E NicolleA Di Pietro
Oct 16, 2015·Critical Reviews in Food Science and Nutrition·José C J M D S MenezesMarc Diederich
Oct 29, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Julien BoccardPierre-Alain Carrupt
Jun 15, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Lili WanChunlin Chen
Oct 3, 2018·Current Medicinal Chemistry·Jiahua CuiLarry M C Chow
Feb 13, 2010·Journal of Biomolecular Screening·Michiro SusaZhenfeng Duan
May 1, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mengmeng XiaXiaoyun Xu
Jul 30, 2009·Cancer Prevention Research·Hong CaiAndreas J Gescher
Feb 26, 2021·Frontiers in Pharmacology·Lee Han JieKhairana Husain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

© 2022 Meta ULC. All rights reserved